- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/16 - Animal cells
Patent holdings for IPC class C12N 5/16
Total number of patents in this class: 1308
10-year publication summary
|
56
|
78
|
85
|
92
|
69
|
61
|
53
|
46
|
38
|
19
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20153 |
19 |
| Regeneron Pharmaceuticals, Inc. | 4370 |
18 |
| F. Hoffmann-La Roche AG | 7946 |
14 |
| The Trustees of the University of Pennsylvania | 4366 |
13 |
| Amgen Inc. | 4122 |
12 |
| The Board of Trustees of the Leland Stanford Junior University | 6494 |
10 |
| Board of Regents, The University of Texas System | 5891 |
10 |
| The University of British Columbia | 1518 |
10 |
| Genentech, Inc. | 4012 |
9 |
| Abbvie Inc. | 1800 |
9 |
| CRISPR Therapeutics AG | 372 |
9 |
| Crystal Bioscience Inc. | 82 |
9 |
| Dana-Farber Cancer Institute, Inc. | 2602 |
9 |
| Kyoto University | 2828 |
8 |
| CHO Plus, Inc. | 14 |
8 |
| Novartis AG | 10707 |
7 |
| Centre National de La Recherche Scientifique | 10595 |
7 |
| The Board of Trustees of the University of Illinois | 2707 |
7 |
| E. R. Squibb & Sons, L.L.C. | 116 |
7 |
| ImmunoGen, Inc. | 401 |
7 |
| Other owners | 1106 |